Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of 1478.363 pence per Ordinary share on 5 January 2012 as a result of the reinvestment of dividends paid on Ordinary Shares held in the GlaxoSmithKline ShareReward Plan ("the Plan").
Sir Andrew Witty |
Acquisition of 7 Ordinary shares
|
Mr S M Bicknell |
Acquisition of 7 Ordinary shares
|
Mr S Dingemans |
Acquisition of 1 Ordinary share
|
Mr E J Gray |
Acquisition of 7 Ordinary shares
|
Mr S A Hussain |
Acquisition of 7 Ordinary shares
|
Dr D Pulman |
Acquisition of 11 Ordinary shares
|
Mr D S Redfern |
Acquisition of 7 Ordinary shares
|
Ms C Thomas |
Acquisition of 7 Ordinary shares
|
Mr P C Thomson |
Acquisition of 13 Ordinary shares
|
Dr P J T Vallance |
Acquisition of 15 Ordinary shares |
Mrs V A Whyte |
Acquisition of 27 Ordinary shares |
The Company and the above-mentioned persons were advised of this information on 6 January 2012.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
6 January 2012